The forecasted data for hospital discharges due to malignant neoplasm of the trachea, bronchus, and lung in the UK indicates a declining trend from 2024 to 2028, with values decreasing from 34.17 thousand to 31.9 thousand discharges. In 2023, the value stood higher than 34.17 thousand. The year-on-year decline varies, averaging a steady decrease of approximately 1.5% annually in the forecasted period. Over five years, the compound annual growth rate (CAGR) reflects a consistent downturn.
Future trends to monitor include advancements in early detection and improved treatment protocols, which could further influence hospital discharge rates, as well as public health initiatives aimed at reducing smoking rates and improving air quality, likely impacting the incidence of such conditions.
